Glenmark Pharmaceuticals today announced that it has become one of the first generic companies to receive United States Food & Drug Administration (USFDA) approval for Arformoterol Tartrate inhalation solution, 15 mcg/2 ml, unit-dose vials, the generic version of Brovana inhalation solution of Sunovion Pharmaceuticals.